05:00
2026-08-08
innolitics.com
ai-products
Cadence Enters TEMPO: What the Second Participant Suggests About the Pilot’s Direction
On August 5, the U.S. Food and Drug Administration (FDA) named Cadence the second participant in its TEMPO pilot program for HypertensionOS, a software device that generates protocol-bound medication-…